This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
This article was written by Follow I am a high-conviction investor and independent analyst focused on accumulating quality compounders at a discount. My investment...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...
Introduction It has been four years since I last discussed Bekaert (OTCPK:BEKSF) (OTCPK:BEKAY) and back in 2019 I argued that Bekaert was worth having...
Earlier this month, President Biden visited South Carolina and announced a $60 million investment by Enphase Energy (ENPH) to manufacture the company’s microverters –...
The MELI Investment Thesis Remains Robust – Made Even More Attractive By The Discount We previously covered MercadoLibre, Inc. (NASDAQ:MELI) in May 2023, ending...
This article was first released to Systematic Income subscribers and free trials on July 9. Welcome to another installment of our Preferreds Market Weekly...